Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar 2gud2btrue (< 20) Submitted: 5/21/2011 7:08:22 AM : Outperform Start Price: $10.55 LGND Score: +21.90

Target $20

Featured Broker Partners


Advertisement